ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

Bharuch, Gujarat: The Gujarat Anti-Corruption Bureau (ACB) on Tuesday caught two officials of the Food and Drugs Control Administration (FDCA) red-handed while allegedly accepting a bribe of ₹40,000 for processing a new wholesale drug licence.

The accused have been identified as Prakashbhai Nanakram Posnani (also referred to as Prakash Posnani), 54, Assistant Commissioner (Class-1) of the Food and Drugs Department in Bharuch, and Surbhiben Desai (also Surbhi Desai or Surabhiben Desai, daughter of Mohanlal Desai), 29, Drugs Inspector (Class-2) with the same department. Both were posted at the FDCA office in Bharuch.

According to ACB accounts corroborated across multiple reports, a complainant (described in one account as a vigilant citizen or trader) had applied for a new wholesale drug licence at the Assistant Commissioner’s office of the Food and Drugs Control Administration in Bharuch. During the processing of the application, Surbhiben Desai allegedly informed the applicant that the licence procedure would be completed but that a sum of ₹40,000 to ₹50,000 would have to be paid to the senior official.

Unwilling to pay the demanded amount, the complainant approached the Narmada ACB Police Station and lodged a formal complaint. Based on the complaint, the ACB laid a trap on August 18, 2026, at the Assistant Commissioner’s chamber in the Food and Drugs Department office in Bharuch.

During the operation, the two officials allegedly accepted ₹40,000 from the complainant. The ACB team immediately intervened, recovered the entire bribe amount on the spot, and arrested both officials. The trap was executed by Police Inspector D.D. Vasava of the Narmada ACB Police Station, with involvement from the ACB Vadodara unit under Assistant Director B.M. Patel, and overall leadership by Deputy Director Baldev Desai of ACB Vadodara, as detailed in reports drawing from official information.

The ACB has alleged that the accused, as public servants, misused their official positions and engaged in criminal misconduct by demanding and accepting the bribe. An offence has been registered under the Prevention of Corruption Act, and further legal proceedings are underway. Both officials have been detained for investigation.

Related Posts

WHO launches new primary health care course to strengthen health systems globally

Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

WHO launches new primary health care course to strengthen health systems globally

WHO launches new primary health care course to strengthen health systems globally

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert